written on 28.03.2014
Tags:
,

Bayer keeps cheap Nexavar copy from being exported from India

TAGS: ,

Chalk up a win for Bayer KGaA in its running battle in India over a compulsory license granted to Natco to produce a cheap knock-off of its cancer drug Nexavar. The drug is being sold in India but a high court there says that is as far as the Indian drugmaker can go with it for now.

Latest Report